You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 諾誠健華-B漲逾4% 獲多家大行看好
格隆匯 04-27 14:52
格隆匯4月27日丨諾誠健華-B(9969.HK)今日盤中高見15.36港元,逼近上週四(23日)盤中創下的歷史最高位15.38港元,現報15.1港元,漲4.57%,暫成交9693萬港元,最新總市值194億港元。高盛最新發研報稱,認為諾誠健華-B有潛力發展為針對性療法的研發差異化平台,因為其具有強大的執行能力,以及其核心項目具商業化的可見度。該行首次給予其“買入”評級,目標價16.6港元。瑞銀亦首予其買入評級,目標價18.13港元。認為公司的市銷率為3.2倍,低於生物科技同業的3.5倍,市場並未完全反映在競爭激烈環境下,集團在中國的潛在市場份額、其BTK抑制劑在海外市場的機會,和其他候選藥物的潛在價值等。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account